東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Biomarkers in cardiovascular disease

Patel, Vinood B.

FindBook

Google Book

Amazon

博客來

Biomarkers in cardiovascular disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Biomarkers in cardiovascular disease/ edited by Vinood B. Patel, Victor R. Preedy.
其他作者:	Patel, Vinood B.
出版者:	Dordrecht :Springer Netherlands : : 2016.,
面頁冊數:	xxix, 1329 p. :ill. (some col.), digital ;24 cm.
內容註:	High-Throughput Approaches to Biomarker Discovery and Challenges of Subsequent Validation -- Mass Spectrometry-Based Lipidomics for Biomarker Research -- Flow Cytometry as Platform for Biomarker Discovery and Clinical Validation -- Pentraxin 3 as Biomarker -- Isoprostanes as Biomarkers of Disease and Early Biological Effect -- Fetal Membranes: Potential Source of Preterm Birth Biomarkers -- 1-Hydroxypyrene as a Biomarker for Environmental Health -- Biomarkers of Necrosis and Myocardial Remodeling -- Serum Heat Shock Proteins as Novel Biomarker for Heart -- Failure and Cardiovascular Diseases -- Traditional and Proteomic Biomarkers of Autosomal Dominant -- Polycystic Kidney Disease (ADPKD) -- Biomarker for Amyotrophic Lateral Sclerosis -- Biomarkers of Vector Bites: Arthropod Immunogenic Salivary Proteins in Vector-Borne Diseases Control -- Biomarkers of Graft-Versus-Host Disease.
Contained By:	Springer eBooks
標題:	Cardiovascular system - Diseases -
電子資源:	http://dx.doi.org/10.1007/978-94-007-7678-4
ISBN:	9789400776784$q(electronic bk.)

Biomarkers in cardiovascular disease
Biomarkers in cardiovascular disease[electronic resource] /edited by Vinood B. Patel, Victor R. Preedy. - Dordrecht :Springer Netherlands :2016. - xxix, 1329 p. :ill. (some col.), digital ;24 cm. - Biomarkers in disease: methods, discoveries and applications. - Biomarkers in disease: methods, discoveries and applications..

High-Throughput Approaches to Biomarker Discovery and Challenges of Subsequent Validation -- Mass Spectrometry-Based Lipidomics for Biomarker Research -- Flow Cytometry as Platform for Biomarker Discovery and Clinical Validation -- Pentraxin 3 as Biomarker -- Isoprostanes as Biomarkers of Disease and Early Biological Effect -- Fetal Membranes: Potential Source of Preterm Birth Biomarkers -- 1-Hydroxypyrene as a Biomarker for Environmental Health -- Biomarkers of Necrosis and Myocardial Remodeling -- Serum Heat Shock Proteins as Novel Biomarker for Heart -- Failure and Cardiovascular Diseases -- Traditional and Proteomic Biomarkers of Autosomal Dominant -- Polycystic Kidney Disease (ADPKD) -- Biomarker for Amyotrophic Lateral Sclerosis -- Biomarkers of Vector Bites: Arthropod Immunogenic Salivary Proteins in Vector-Borne Diseases Control -- Biomarkers of Graft-Versus-Host Disease.

On an annual basis, over 17 million people die due to cardiovascular disease. This represents a third of all global deaths. The World Health Organisation have identified cardiovascular disease as the leading cause of death worldwide. Although many cardiovascular conditions are preventable, there is a need for accurate characterisation and diagnosis of cardiovascular conditions before, during and after treatments. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Cardiovascular Disease combines detailed information on different cardiovascular conditions and the concomitant application of conventional, new and emerging biomarkers. It covers the latest knowledge, trends and applications. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry.

ISBN: 9789400776784$q(electronic bk.)

Standard No.: 10.1007/978-94-007-7678-4doiSubjects--Topical Terms:

907466
Cardiovascular system
--Diseases

LC Class. No.: RC669.9

Dewey Class. No.: 616.1

Biomarkers in cardiovascular disease
LDR:02787nmm a2200325 a 4500 001 2052490
003 DE-He213
005 20160901165721.0
006 m d
007 cr nn 008maaau
008 170421s2016 ne s 0 eng d
020 $a 9789400776784$q(electronic bk.)
020 $a 9789400776777$q(paper)
024 7 $a 10.1007/978-94-007-7678-4 $2 doi
035 $a 978-94-007-7678-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC669.9
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.1 $2 23
090 $a RC669.9 $b .B615 2016
245 0 0 $a Biomarkers in cardiovascular disease $h [electronic resource] / $c edited by Vinood B. Patel, Victor R. Preedy.
260 $a Dordrecht : $b Springer Netherlands : $b Imprint: Springer, $c 2016.
300 $a xxix, 1329 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Biomarkers in disease: methods, discoveries and applications
505 0 $a High-Throughput Approaches to Biomarker Discovery and Challenges of Subsequent Validation -- Mass Spectrometry-Based Lipidomics for Biomarker Research -- Flow Cytometry as Platform for Biomarker Discovery and Clinical Validation -- Pentraxin 3 as Biomarker -- Isoprostanes as Biomarkers of Disease and Early Biological Effect -- Fetal Membranes: Potential Source of Preterm Birth Biomarkers -- 1-Hydroxypyrene as a Biomarker for Environmental Health -- Biomarkers of Necrosis and Myocardial Remodeling -- Serum Heat Shock Proteins as Novel Biomarker for Heart -- Failure and Cardiovascular Diseases -- Traditional and Proteomic Biomarkers of Autosomal Dominant -- Polycystic Kidney Disease (ADPKD) -- Biomarker for Amyotrophic Lateral Sclerosis -- Biomarkers of Vector Bites: Arthropod Immunogenic Salivary Proteins in Vector-Borne Diseases Control -- Biomarkers of Graft-Versus-Host Disease.
520 $a On an annual basis, over 17 million people die due to cardiovascular disease. This represents a third of all global deaths. The World Health Organisation have identified cardiovascular disease as the leading cause of death worldwide. Although many cardiovascular conditions are preventable, there is a need for accurate characterisation and diagnosis of cardiovascular conditions before, during and after treatments. Much of this characterisation entails the use of biological indicators, i.e biomarkers. Biomarkers in Cardiovascular Disease combines detailed information on different cardiovascular conditions and the concomitant application of conventional, new and emerging biomarkers. It covers the latest knowledge, trends and applications. New platforms are described which combine advances in biomedical sciences, physics, computing and chemistry.
650 0 $a Cardiovascular system $x Diseases $x Molecular aspects. $3 907466
650 0 $a Biochemical markers. $3 587592
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Cancer Research. $3 891172
650 2 4 $a Oncology. $3 751006
650 2 4 $a Pharmacology/Toxicology. $3 890953
700 1 $a Patel, Vinood B. $3 1613841
700 1 $a Preedy, Victor R. $3 616207
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Biomarkers in disease: methods, discoveries and applications. $3 3135880
856 4 0 $u http://dx.doi.org/10.1007/978-94-007-7678-4
950 $a Biomedical and Life Sciences (Springer-11642)